ArticleFrontiers in genetics2025
Key gene screening and diagnostic model establishment for acute type a aortic dissection.
Article in Frontiers in genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Centroid Regression for Preoperative Risk Assessment of Acute Type A Aortic Dissection Based on Multivariate Clinical Data.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Aortic dissection, particularly acute type A aortic dissection (ATAAD), is a life-threatening cardiovascular emergency with alarmingly high mortality rates globally. Despite advancements in imaging techniques like computed tomography angiography (CTA), delayed diagnosis and incomplete understanding of molecular mechanisms persist, contributing to poor outcomes. Recent studies highlight the role of immune dysregulation, vascular smooth muscle cell (VSMC) apoptosis, and metabolic-epigenetic interactions in AD pathogenesis, underscoring the need for novel biomarkers and therapeutic targets. Objective: This study aims to identify critical genes and molecular pathways associated with ATAAD, develop a multi-omics diagnostic model, and evaluate potential therapeutic interventions to improve clinical outcomes. Methods: Transcriptome datasets from the Gene Expression Omnibus (GEO) database were analyzed using differential expression analysis, weighted gene co-expression network analysis (WGCNA), and machine learning algorithms (SVM, Random Forest, LASSO regression). Functional enrichment and immunoinfiltration analyses were performed to explore biological pathways and immune cell interactions. External dataset validation and PCR testing of clinical samples (n = 9) were conducted to confirm gene expression differences. A nomogram diagnostic model was constructed and evaluated for predictive accuracy. Results: Six core genes were identified: Conclusion: This study identifies key molecular markers and pathways in ATAAD pathogenesis, emphasizing the role of immune dysregulation and extracellular matrix remodeling. The multi-omics diagnostic model provides a novel tool for early screening, potentially reducing mortality through timely intervention. These findings advance the understanding of aortic dissection mechanisms and offer actionable targets for future research and clinical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.